Introduction
Thirty years have passed since the first ancient DNA (aDNA) analyses, largely made possible by the advent of the polymerase chain reaction (PCR) in 1985. As early as 1993, researchers began to target ancient pathogens such as Mycobacterium tuberculosis, Mycobacterium leprae, Treponema pallidum, Yersinia pestis and the influenza virus [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . These pioneering studies were largely limited to identifying the presence of the pathogen in archaeological bone or tissue, often by focusing on repetitive or high copy number sequences or by targeting a few phylogenetically informative sites, and were often controversial [11] [12] [13] [14] . The noted exceptions were the studies of the 1918 flu virus and early HIV samples where small complete genomes were accessible via PCR and Sanger sequencing alone [15, 16] .
Over the past decade, however, technical advances in library construction, enrichment and sequencing, specifically for aDNA [17] [18] [19] [20] [21] , have revolutionized pathogen aDNA studies. These 'next-generation' methods enable the study of complete genomes and of samples with little remaining endogenous DNA [22 -25] , thereby allowing direct access to the evolutionary timescale inherent in heterochronously sampled individuals [26 -28] . Additionally, bioinformatics tools that estimate postmortem damage characteristic for aDNA fragments offer greater confidence in establishing authenticity [29, 30] . Current protocols can capture complete pathogen genomes that comprise a very small portion of the endogenous DNA in a sample [31, 32] and thus shed light on questions about the causative agents of disease and epidemics, the evolutionary history of pathogens, and co-infection with multiple strains or species [33] .
In the current era of 'omics', aDNA research remains restricted by the highly variable biomolecular preservation of each bone, tooth or tissue fragment.
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To maximize the application of next-generation methods, it is beneficial first to identify positive candidate samples for downstream procedures, ultimately reducing reagent costs, increasing capture efficiency and maximizing the number of sequencing reads of the target. Quantitative PCR (qPCR), which is widely used in modern diagnostics, offers a rapid, sensitive and economic method that assesses the presence and preservation of nucleic acids, and is known to be a reliable screening tool for identifying samples that have sufficient endogenous DNA preservation to warrant deeper sequencing [34, 35] . This study reports the results of four qPCR assays designed specifically for detection of Mycobacterium tuberculosis complex (MTBC) DNA in over 130 archaeological human remains from 29 sites in the New and Old World. We find that qPCR continues to be a rapid and dependable screening tool, but care must be taken in primer and probe design to avoid false-positives and to properly accommodate pathogen diversity.
(a) Previous tuberculosis aDNA research MTBC includes a group of pathogenic mycobacteria that cause disease in both animals and humans. M. tuberculosis is the species most commonly associated with clinical tuberculosis (TB) in humans, although members of the complex that are adapted to other mammalian hosts such as bovids, rodent and pinnipeds, as well as the ancestral M. canettii [36] also cause disease in humans.
Human-adapted TB strains are a major cause of mortality and morbidity worldwide, exacerbated by a recent resurgence driven by HIV co-infection and the development of antibiotic resistant forms. The global prevalence and virulence of TB today is the culmination of host -pathogen interactions that extend across millennia, although when these interactions began is controversial [37] [38] [39] [40] . The antiquity of the disease is well documented by historians, archaeologists and palaeopathologists, relying primarily upon skeletal evidence for disease consistent with modern, clinical bone lesions in extrapulmonary TB patients (see [41, 42] ). Advancements in aDNA research can, in turn, be applied to molecular investigations of affected skeletal remains to address the evolutionary history of this remarkably enduring pathogen.
Many of the earliest pathogen aDNA studies focused on TB, with the presence of ancient MTBC DNA first reported in the early 1990s [7, 9] . These studies used PCR solely to identify the presence or absence of pathogenic bacilli in bone or mummified tissue. Isolating a small fraction of pathogen DNA within an archaeological sample poses a technical challenge and is further complicated by the close genetic relationship of most pathogenic bacteria to those of environmental origin, which are easily introduced from the burial environment [43] . Direct sequencing of ancient products, or clones thereof, is required to authenticate ancient PCR results [44] . However, genetic regions commonly used for PCR-based detection of MTBC DNA are homologous in some related soil mycobacteria, such as the IS6110 mobile element [45, 46] and the rpoB gene (discussed in §2a). Additional regions used in past investigations have related homologues in non-tuberculous mycobacteria (NTM): IS1395 in M. xenopi, for example, shares 86% sequence identity with the IS1081 element of the MTBC [47] . If primers are located in conserved regions, homology can cause false-positive PCR results in NTM, as shown by Savelkoul et al. [48] with the IS6110 element. Ideally, primers should target regions with enough genetic diversity to avoid false-positives from related bacteria, and should be evaluated manually through multiple sequence alignments or by using search features of online databases such as NCBI's Basic Local Sequence Alignment Search Tool. Unfortunately, our understanding of environmental mycobacterial sequence diversity is limited by available data; in other words, sequence alignments may not represent the true amount of diversity amplifiable with a given primer set. Thus, performing periodic cross-checks of primer pairs as new data become accessible helps ensure the PCR target regions remain specific.
With the availability of more extensive sequence information and improved methods of detection, ancient TB studies are moving from mere identification to more complex and more intriguing questions about the history and evolution of the MTBC across host species and through time [33, 49] . The rapid identification of well-preserved DNA remains the first step in the costly current state of ancient TB research.
(b) Detecting ancient DNA via quantitative real-time PCR qPCR is capable of detecting short and low-quantity starting templates and thus has many applications for ancient genetics, as reviewed by Bunce et al. [50] . Taqman qPCR technology provides additional specificity over SYBR chemistries by including a non-extendable DNA probe, which hybridizes to a region within the amplicon, reducing the amplification of non-specific molecules [51] . The assumption when targeting aDNA is that the fragment of interest is conserved enough to be amplified by the primers/probe set. If the assumption is incorrect, or if miscoding lesions and other damage common to aDNA occur at crucial binding sites, qPCR efficiency is reduced, mimicking the amplification curves of a sample co-extracted with inhibitory substances [52] .
Aside from mismatches, a number of other factors affect the success and efficiency of an amplification reaction, including production of secondary structures, repetitive sequences and high GC/AT content [53] [54] [55] . Such factors are further compounded when templates are degraded, damaged and low in quantity [50, 52, [56] [57] [58] . While we are often concerned with false-positives in ancient DNA, inhibition can cause falsenegatives-an equally undesirable result. Methods are being developed continuously to improve retention of endogenous molecules and to reduce the quantity of inhibitors co-extracted during purification [59] [60] [61] . In addition, creating a dilution series with an ancient extract, while reducing the number of endogenous templates, can reveal the presence of inhibitory substances. A 10-fold dilution theoretically amplifies 3.32 PCR cycles later than an undiluted sample. Deviations from this pattern owing to delays in amplification of undiluted samples provide an indication of PCR inhibition. Similarly, levels of inhibition are gauged by examining variation in the slopes of exponential amplification plots, spiking internal controls with ancient extracts [52] or by simultaneously running UNG-treated extracts in parallel [62] . Unfortunately, the exact chemistry of each qPCR can differ; according to Huggett et al. [63] : 'It is possible for one PCR to be unaffected by a potential inhibitor whilst another is completely suppressed'. Late occurring or non-exponential amplification often is seen with both inhibited and low-copy number samples as well as with template mismatches [64, 65] ; consequently, the cycle numbers are often increased compared with conventional PCR with modern template.
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Interpretations of qPCR data rely on user-based threshold and baseline determinations. Therefore, quantification estimates in the qPCR software output must be interpreted with care. Given the obstacles of quantifying aDNA and the potential inaccuracies of copy number estimates, a simple presence/ absence determination for a target sequence may be the most appropriate level of resolution, rather than relying on quantity estimates when qPCR is used as a screening tool for downstream analyses.
Material and methods
The objective of this research is to screen archaeological human remains for preserved MTBC DNA and to identify candidates for targeted enrichment and genome sequencing on next-generation sequencing (NGS) platforms. We examined 133 human skeletal samples from a wide geographical and temporal range identified by the presence of skeletal lesions typical of skeletal TB, listed in table 1 and the electronic supplementary material, table S1 . Despite methodological advances, sample preparation and contamination remain critical considerations. Contaminant DNA, even at low quantities, can be preferentially amplified [66] . Ancient genetic research benefits from stringent, well-defined and controlled procedures for nucleic acid isolation, which are requisite for any aDNA facility [67, 68] . All work performed in this investigation was carried out in the Ancient DNA Laboratory at Arizona State University. This facility is separated from post-PCR laboratories and contains a positive pressure class 10 000 HEPA-filtered clean room, UV irradiated every evening and after every use, as is standard practice [44] . All personnel and reagents maintain a unidirectional workflow between ancient and modern DNA facilities to eliminate post-PCR contamination. Disposable facemask, double gloves and hooded coveralls are worn at all times; gloves are changed between samples. After each use, surfaces, bench top equipment and pipettes are washed with bleach, 70% ethanol and sterile water. Bone fragments and teeth were briefly rinsed with 3% bleach and sterile water to remove surface contaminants. Between 50 and 250 mg of bone powder was used in each extraction. Four silica and spin-column-based extraction protocols were used over the course of the project [22, 60, 69, 70] . Contamination during DNA extraction was evaluated with extraction blanks; 5 ml of each extract and blank was used in conventional PCR to test for presence of an 80 bp region of human mtDNA [71] . Extraction blanks showing any potential human contamination were re-extracted. PCR blanks also confirmed uncontaminated reactions.
(a) qPCR assays
The presence and quantity of MTBC DNA in each extract were examined with four separate TaqMan qPCR assays, two targeting the single-copy rpoB gene, referred to as rpoB1 and rpoB2, and two targeting multi-copy insertion elements, IS6110 and IS1081, thought to be specific to the MTBC complex [72] [73] [74] [75] . The rpoB2 and IS1081 primer/probe sequences were designed for this investigation (table 2) . The IS6110 primer/probe set targets a 63 bp fragment that avoids a region of homology in other mycobacterial species as identified by McHugh et al. [46] (see [76] ). Although the rpoB1 assay reportedly contains 15 differences between the MTBC ecotypes and other mycobacterial species [76] , a multiple alignment of newly available mycobacterial sequences showed that the rpoB1 probe/primers could amplify species outside the complex. In testing this observation, the rpoB1 qPCR assay detected the presence of species outside the MTB complex, including M. marinum, M. avium, M. leprae, M. kansasii and M. lufu. As discussed in §1b, PCR efficiency is negatively impacted if mismatches or inhibition are present. Interestingly, we observe a number of non-exponential or late amplification signals that mimic results caused by inhibition and/or mismatches. A representative multiple sequence alignment is crucial for MTBCspecific primer design, because mismatches between the reference and closely related bacteria can be placed at the 3 0 or 5 0 priming sites, known to affect binding efficiency most heavily [77] . To reduce the risk of mispriming, our redesigned rpoB2 assay amplifies a 70 bp region where nucleotide differences are most heavily concentrated at the 3 0 and 5 0 ends of the primers and probe, respectively, thus increasing specificity of the intended product within the MTBC.
To evaluate whether non-specific products, such as primerdimers, are recorded as false-positives, 51 sterile water samples were amplified with our rpoB1 and IS6110 assays for 60 cycles. No non-specific products were recorded with IS6110. For rpoB1, seven wells displayed a late amplifying curve, crossing the threshold after 50 cycles (n ¼ 6), and at 46 cycles (n ¼ 1). These false-positives underscore the caution taken during data analysis, particularly with the rpoB1 locus.
All ancient extracts and a subset of extract dilutions (1 : 10, 1 : 100) were tested for each of these regions by comparison with a standard curve of serial dilutions created from genomic DNA of M. tuberculosis H37rv (ATCC 25618 or ATCC 27294) in a 10-fold serial dilution of 1-100 000 copy numbers per microlitre, optimized for each assay. It is important to note that once the ancient samples are loaded into the qPCR plate in the cleanroom, they are sealed and not reopened in any post-PCR laboratory; the standards are then loaded into one corner of the plate that remains unsealed. The primers used for the standard and unknown ancient samples are identical and thus produce the same amplicon; fluorescence is recorded only when the probe hybridizes to the target sequence. In each run, two or three replicates, depending on available extract, of each ancient sample are included, and non-template controls are included in triplicate. Reactions are in a 20-ml total volume; 10 ml of TaqMan 2x Universal Master Mix, primers, probe (see table 2 for primer/probe sequence and concentration), 10 mg ml 21 RSA and 2 ml of sample. Thermocycling conditions for the ABI 7900 consisted of an initial enzyme activation at 958C for 10 min, followed by 45-50 cycles at 958C for 15 s and 608C for 1 min.
Results and discussion
Our qPCR screening of archaeological skeletal remains identified 28 samples with evidence of mycobacterial DNA, but nine with evidence for MTBC-specific DNA (i.e. excluding rpoB1), with seven of those positive for multiple loci. To avoid misinterpreting false-positives identified by the software's output, each sample was evaluated individually. With low-copy number templates, as expected with ancient material, fluorescence often occurred relatively late in the reaction and had to be evaluated against any low-level background signal. Multi-component plots were used in late amplifications to evaluate each replicate's fluorescence signal crossing over the background signal or the passive reference before confirming the well as positive. A sample extract is considered positive for an assay if more than 50% of all replicates cross the automatic or user-defined threshold. With these criteria, 28 of 133 samples showed a positive signal in at least one of the four qPCR assays. These data are listed in table 3 and electronic supplementary material tables.
To evaluate inhibition, extract dilutions of a subsample (n ¼ 32) were also tested, revealing at least seven inhibited samples. Inhibition can produce not only false-negative results, but also prohibit reliable estimation of starting copy numbers when compared with a standard of known quantity, in some cases producing theoretically impossible values that are well below one copy number (see amplification plot in figure 1) . In eight extracts, amplification signals were recorded only in the dilutions, but not in the undiluted extract, only some of which met the 50% positive replicate criterion. Five samples showed lower or similar C t -values in the dilutions compared with the raw extracts, rather than approximately þ3.32 cycle difference expected. The five potentially inhibited samples categorized as negative with our criteria could be considered again if further measures are taken to address inhibition. Nevertheless, it is useful information for downstream steps. As mentioned earlier, the rpoB1 assay amplified a conserved gene region in species outside the complex at low levels. By factoring in additional sequence information and mismatch placement, our redesigned assay, rpoB2, achieved increased strain specificity. We therefore omit rpoB1 in our discussion of positive MTBC results, although all assays are reported in the electronic supplementary material, table S3. With this additional criterion, nine samples are positive for at least one of the remaining three assays: IS1081 (n ¼ 7), IS6110 (n ¼ 7), rpoB2 (n ¼ 7). These samples are located throughout North and South America (figure 2). In most cases, the same and/or a new extraction of each sample were repeated. Extraction blanks associated with these samples were negative in all assays for MTBC DNA, as were non-template controls. Most convincing as candidate samples were those positive for multiple (2þ) MTBC loci. These include samples from seven sites: one historic (Highland Park) and one proto-historic site (Arikara) in North America and five pre-contact South American sites, Chiribaya Alta (sample 54), El Algodonal (sample 58), El Yaral (sample 64), Las Delícias y Candeleria (sample 281) and Estuquiñ a (sample 82). All efforts to clone and/or direct sequence the qPCR product via Sanger sequencing were unsuccessful, the latter likely owing to short amplicon length and/or low DNA concentration. We acknowledge that it is impossible to authenticate ancient fragments with PCR data alone, and that the qPCR results were used primarily for identifying candidate samples for targeted enrichment. Four of the seven positive samples listed above from Chiribaya Alta, El Algodonal, El Yaral and Estuquiñ a were independently replicated by in-solution capture designed to target genes within the MTBC [40] . Sample 128 (Highland Park) did not meet the cut-off for full genome capture, but nonetheless showed some reads mapping to MTBC (see [40] ). Three of these four positive samples (54, 58, 64) were enriched further, generating three complete genome sequences [59] . The genome enrichment for the fourth sample (82) is underway. The two remaining samples testing positive for multiple assays in our qPCR screening (15, 281) only did so after extraction with a newer protocol [22] , which could account for the discrepancy between qPCR and the negative in-solution enrichment results. Re-analysis of earlier qPCR data as well as newly tested extracts from Lambayeque ILL-22, reported positive in reference [76] , reveals the absence of IS6110 and other MTBC loci, according to our stricter criteria. Likewise, bone from Chiribaya Alta T-30, originally detected from mummified lung tissues reported in reference [7] , was not found to be positive in this study. This negative result may highlight a fundamental difference in recovering pathogen DNA from different tissue types. Interestingly, four of the seven most well-preserved MTBC-positive samples are from four sites located in the Osmore River valley on the coast of southern Peru (figure 2). This general region has been the focus of other bioarchaeological, palaeopathological and molecular investigations of ancient TB [10, 78, 79] . Identification of acid-fast bacilli within a paravertebral abscess in a subadult near Nasca, Peru (AD 200-800) [80] , and diagnostic lung lesions from mummified remains at Chiribaya Alta were among the first reports of ancient TB DNA in the area and in the world [7] , though our analysis of bone from the latter individual was negative for qPCR. Most recently, as Bos et al. [40] report, the individuals from three sites along the Osmore River drainage share a unique MTBC strain most closely related to M. pinnipedii, a pathogen of marine mammals. The arid desert of Peru's southern coast likely contributes to the surprisingly high recovery of positive MTBC cases in our study. An increasing number of skeletal cases in the region approaching AD 1000 suggests this area could have been a hotspot of ancient 'tuberculosis' [41] . This is not surprising considering TB-like diseases are density-dependent. The expanding evidence that humans were infected with pathogenic MTBC DNA in pre-contact South America provides a new starting point to examine the larger, evolutionary questions regarding the origin, dispersal and adaptation of this disease-causing clade of mycobacteria; 
Conclusion
Moving beyond simple confirmatory analysis of diseased bone, researchers are now asking nuanced research questions capable of confronting the debate regarding TB's origins and evolution. These questions continue to be at the forefront of not only ancient pathogen research, but also (bio)archaeological and palaeopathological scholarship. Here, we report the results of screening for presence of mycobacterial DNA archaeological skeletal remains. The speed of these analyses is unrivalled compared with screening with other methods, for example, in-solution capture; in a 384-well plate, results for multiple samples are available in less than 3 h and require no high-throughput computation. Using multiple qPCR loci currently thought to be specific for the TB complex, we report nine positive samples from skeletons ranging in age from AD 770 to as late as AD 1850 from the Americas. It is important to note that mycobacterial species other than M. tuberculosis sensu stricto can cause TB-like disease in humans, and thus focused MTBC assays are best designed around conserved regions within the complex that differ from species outside the complex at crucial binding sites. Although the rpoB1 qPCR assay alone could not be used to determine the presence of MTBC DNA, there remains a possibility that samples identified solely with rpoB1 reflect zoonotic events by other related mycobacteria, for example, M. avium; such events could be the topic of further investigation. In summary, there are several ways to overcome the obstacles of using damaged, degraded DNA in qPCR analyses: (i) stringency in sample preparation to reduce co-extraction of inhibitors; (ii) Taqman probe-based assays to increase sensitivity of detection; (iii) regular in silico re-examination of newly published sequence data and when appropriate, primer/ probe redesign, (iv) serial dilutions of extractions to evaluate inhibition, and (v) use of multiple replicates in evaluating a positive signal. If no enrichment/sequencing projects are planned with the candidate samples, direct sequencing can strengthen claims of authenticity. Reporting the presence or absence of pathogen aDNA is no longer an acceptable final research objective, and as Burgess [79] expressed, its simple detection tells us little of value about the existence of the disease in the past. NGS genome data are the new objective for ancient pathogen research. Improving molecular techniques, specifically whole genome sequencing of modern MTBC strains, continues to strengthen investigations of the microevolutionary processes that contribute to virulence and the host-pathogen coevolution of the TB disease complex [37, 82] . While in its nascent stages, this level of ancient data acquisition portends investigations on the same scale as modern genomics.
Ultimately, there are known limits to qPCR, and it is important to avoid over-interpreting data and to be conservative in each evaluation to avoid false-positives. In aDNA, the adage that the absence of evidence is not evidence of absence certainly plays a role in sample choice and experimental design. It is expectable and demonstrated here that samples qPCR positive for multiple MTBC loci were the best indicators of aDNA preservation for full genome reconstruction. As a proxy for downstream analyses, probe-based qPCR technology remains a fast and more cost-effective assessment of aDNA preservation when compared with screening by more expensive enrichment and sequencing technologies.
